Moreover, LCN2 deletion improved insulin sensitivity in adipose tissue of diet-induced obesity [9] or attenuated non-alcoholic steatohepatitis (NASH) progression in the liver of methionine- and choline-deficient-diet mice [10]. Here, LCN2 is linked to metabolic dysfunction-associated steatohepatitis.